Cargando…

Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy

BACKGROUND AND AIMS: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Batistaki, Chrysanthi, Pandazi, Aggeliki, Kyttari, Aikaterini, Kaminiotis, Evangelia, Kostopanagiotou, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598587/
https://www.ncbi.nlm.nih.gov/pubmed/31303711
http://dx.doi.org/10.4103/joacp.JOACP_42_17
_version_ 1783430804367474688
author Batistaki, Chrysanthi
Pandazi, Aggeliki
Kyttari, Aikaterini
Kaminiotis, Evangelia
Kostopanagiotou, Georgia
author_facet Batistaki, Chrysanthi
Pandazi, Aggeliki
Kyttari, Aikaterini
Kaminiotis, Evangelia
Kostopanagiotou, Georgia
author_sort Batistaki, Chrysanthi
collection PubMed
description BACKGROUND AND AIMS: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. MATERIAL AND METHODS: This was a randomized, double-blind controlled trial, performed in patients aged 18–75 years, American Society of Anesthesiologists (ASA) I–III, who underwent a laparoscopic cholecystectomy under deep neuromuscular blockade with rocuronium. Patients received 5 mg of dexamethasone or placebo (N/S 0.9%) during induction of anesthesia. Sugammadex 4 mg/kg was administered at the end of surgery at post-tetanic count 1–2. The outcome measures assessed were the time from sugammadex administration until train-of-four (TOF) 0.9, and until patient's extubation, postoperative pain (measured by numeric rating scale 0–10), nausea and vomiting, as well as rescue analgesics and antiemetics required during the first 24 hours postoperatively. The total dose of rocuronium required in both groups was also recorded. RESULTS: Overall, 44 patients were studied. No difference was detected regarding the demographic and surgical characteristics of patients. The time from sugammadex administration until TOF 0.9 and until patients' extubation did not differ significantly between the groups (P = 0.21 and 0.17). Operating conditions, pain scores, nausea/vomiting, and rescue analgesics and antiemetics during the first 24 hours postoperatively, did not differ between the groups. The total dose of rocuronium, however, was significantly more in patients who received dexamethasone (P = 0.01). CONCLUSION: No significant clinical interaction was revealed between dexamethasone and sugammadex during reversal of deep neuromuscular blockade in patients undergoing laparoscopic cholecystectomy.
format Online
Article
Text
id pubmed-6598587
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-65985872019-07-12 Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy Batistaki, Chrysanthi Pandazi, Aggeliki Kyttari, Aikaterini Kaminiotis, Evangelia Kostopanagiotou, Georgia J Anaesthesiol Clin Pharmacol Original Article BACKGROUND AND AIMS: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. MATERIAL AND METHODS: This was a randomized, double-blind controlled trial, performed in patients aged 18–75 years, American Society of Anesthesiologists (ASA) I–III, who underwent a laparoscopic cholecystectomy under deep neuromuscular blockade with rocuronium. Patients received 5 mg of dexamethasone or placebo (N/S 0.9%) during induction of anesthesia. Sugammadex 4 mg/kg was administered at the end of surgery at post-tetanic count 1–2. The outcome measures assessed were the time from sugammadex administration until train-of-four (TOF) 0.9, and until patient's extubation, postoperative pain (measured by numeric rating scale 0–10), nausea and vomiting, as well as rescue analgesics and antiemetics required during the first 24 hours postoperatively. The total dose of rocuronium required in both groups was also recorded. RESULTS: Overall, 44 patients were studied. No difference was detected regarding the demographic and surgical characteristics of patients. The time from sugammadex administration until TOF 0.9 and until patients' extubation did not differ significantly between the groups (P = 0.21 and 0.17). Operating conditions, pain scores, nausea/vomiting, and rescue analgesics and antiemetics during the first 24 hours postoperatively, did not differ between the groups. The total dose of rocuronium, however, was significantly more in patients who received dexamethasone (P = 0.01). CONCLUSION: No significant clinical interaction was revealed between dexamethasone and sugammadex during reversal of deep neuromuscular blockade in patients undergoing laparoscopic cholecystectomy. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6598587/ /pubmed/31303711 http://dx.doi.org/10.4103/joacp.JOACP_42_17 Text en Copyright: © 2019 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Batistaki, Chrysanthi
Pandazi, Aggeliki
Kyttari, Aikaterini
Kaminiotis, Evangelia
Kostopanagiotou, Georgia
Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
title Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
title_full Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
title_fullStr Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
title_full_unstemmed Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
title_short Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
title_sort is there an interaction between dexamethasone and sugammadex in real clinical conditions? a randomized controlled trial in patients undergoing laparoscopic cholecystectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598587/
https://www.ncbi.nlm.nih.gov/pubmed/31303711
http://dx.doi.org/10.4103/joacp.JOACP_42_17
work_keys_str_mv AT batistakichrysanthi isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy
AT pandaziaggeliki isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy
AT kyttariaikaterini isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy
AT kaminiotisevangelia isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy
AT kostopanagiotougeorgia isthereaninteractionbetweendexamethasoneandsugammadexinrealclinicalconditionsarandomizedcontrolledtrialinpatientsundergoinglaparoscopiccholecystectomy